SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Serono SA

Headquarters : Chemin des Mines 15 bis 1211 Geneva 20 Switzerland Switzerland
Job offers, investor relations : web www.serono.com tel. 41-22-739-3000 email: investor.relations@serono.com stock : SRA analytics

Brands

name
click to compare prices
Ares-Serono
fertility.com, fertilitylifelines.com
Gonal-F
Rebif
Serono , Syntonix Pharmaceuticals
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Serono SA , group Merck KGaA and subsidiaries

Fraud 4 Offshore 6
[click on the rating for the method or on the number for the data]
shareholdercountry%source
Merck KGaAGermany100Bloomberg
» More shareholders of Serono SA
year
business
source
2004Largest biotechnology group in Europe and third-largest in the world.Les Echos
» More business descriptions and market shares for Serono SA.
subsidiarycountry%source
Serono Genetics Institute ex-Genset France86Les Echos
» More subsidiaries of Serono SA
country
address & contact : production type
incentive source
South Africa South Africa
Serono South Africa (Pty) Ltd :
 
Argentina Argentina
Serono Argentina S.A. :
 
Brazil Brazil
Serono Produtos Farmaceuticos Ltda :
 
Colombia Colombia
Serono de Colombia S.A. :
 
South Korea South Korea
Serono Korea Co. Ltd. :
 
Hong-Kong Hong-Kong
Serono Hong Kong Ltd. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Cayman Islands Cayman Islands
Serono 92 Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Cayman Islands Cayman Islands
Serono International Services Limited. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Mexico Mexico
Serono de Mexico S.A. de C.V. :
 
Czech Republic Czech Republic
Serono Genetics Institute S.A. :
 
Singapore Singapore
Serono Singapore Pte Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
Horizon North SA :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Switzerland Switzerland
Ares Trading S.A. :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Thailand Thailand
Serono (Thailand) Co., Ltd. :
 
Turkey Turkey
Serono Ilaç Pazarlama ve Ticaret A.S. :
 
Uruguay Uruguay
Zona franca de Montevideo :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s) ZFM News
Venezuela Venezuela
Serono de Venezuela S.A. :
 
» More locations of Serono SA
» The World map of tax haven, secret accounts and shell companies

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2004Theurillat, Jacques
See the photo of: Theurillat, Jacques Chief Financial Officer;
Boursorama
2003Firouz, Fereydoun
See the photo of: Firouz, Fereydoun Chairman;
2003Muller, Georges
See the photo of: Muller, Georges Chairman;
2003Naef, Francois
See the photo of: Naef, Francois Vice-president;
2002Shaw, Allan
See the photo of: Shaw, Allan Chief Financial Officer;
Boursorama
2000Bertarelli, Ernesto
See the photo of: Bertarelli, Ernesto Chief Executive Officer;
1996Theurillat, Jacques
See the photo of: Theurillat, Jacques Chief Financial Officer;
Boursorama
» More executive salaries for Serono SA
» Highest paid executives in 2007
year
employees
<>
social impact : country
source
2007
-60
Merger/Acquisition: After its merger with Merck, Serono closes its Boulogne (92) headquarters. Administrative jobs are relocated in Lyon.: France
Les Echos
2004
"In 2004, we closed our manufacturing facility in Israel, which was one of our oldest manufacturing sites and had become obsolete.":
2003
4597
2000
4268
» More restructuring at Serono SA
» Layoff plans and labour conditions in 2007
year
employees
<>
social impact : country
source
 4 informations, access to subscribers
» More restructuring at Serono SA
» Layoff plans and labour conditions in 2007

  • Subsidy

yearfinancial misdemeanorsalesincome source
2005 Les autorités de santé des Etats-Unis soupçonnent Serono d'avoir surfacturé le Serostim, un traitement du Sida. Serono paye 704 millions de dollars pour mettre un terme aux poursuites. Serono sera exclu des programmes sanitaires des Etats-Unis pendant 5 ans.     Les Echos
2005 Enquête du procureur de Boston (Etats-Unis) sur la fixation des prix du Serostim aux grossistes et sur des pratiques commerciales.     Les Echos
2003   1,860,39   billion US$
2002   1,550,32   billion US$
2001   1,380,32   billion US$Les Echos
2000   1,150,3   billion US$
» More financial data for Serono SA
» Financial delinquency in 2007
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 6 informations, access to subscribers
» More financial data for Serono SA
» Financial delinquency in 2007
year
purpose : intermediary/lobby : institution
source
2004Prescription de Serostim, un médicament produit par le groupe : : Médecins translateSwissinfos
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
1999Market admission for genetically modified organisms : EuropaBio : : European Commission translateCorporate Europe Observatory
» More influence from Serono SA
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 4 informations, access to subscribers
» More influence from Serono SA
» Influence in 2007
year
dubious practice : image
source
2004Arguable partnership: To further support couples with fertility health concerns, the comprehensive fertility.com and fertilylifelines.com websites were developed and launched in 2004. Serono is also sponsoring the Assisted Conception Taskforce (ACT), a group of healthcare professionals and patient representatives from around the world. ACT's overall objective is to empower coupes that are having difficulty conceiving and their healthcare providers through education and support. ACT also aims to launch an awareness campaign to address public misunderstanding about assisted conception. OUr goal is to continue to strenghten our leadership position in this therapeutic area. We have the opportunity to grow the fertility market by increasing patient awareness of the disease and the availability of treatment sot that more patients receive effective treatment and achieve the dream of their lives, to have a baby.:
2003
» More ads and public relations campaign from Serono SA
» Dubious practices in 2007
Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS